Definium Therapeutics price target raised to $75 from $57 at Baird
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
DFTX target raised to $75 by Baird; current price is $42.79. Upside implied by target above current level.
Target: $75
Posted price: $42.79
Analyst firm: Robert W. Baird
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.